Antihypertensive activity of secoisolariciresinol diglucoside (SDG) isolated from flaxseed: Role of guanylate cyclase

International Journal of Angiology

Volumn 13, Issue 1, 2004, Pages 7-14

  Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GUANYLATE CYCLASE; METHYLENE BLUE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SECOISOLARICIRESINOL;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; ENZYME INHIBITION; HEART RATE; LINSEED; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE;

EID: 2942659072     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1276442     Document Type: Article

References (54)

1. Hettiarachchy NS, Hareland GA, Ostenson A, Bladner-Shank G (1990) Chemical composition of 11 flaxseed varieties grown in North Dakota. Proc Flax Inst 53:36.
2. Oomah BD, Mazza G (1993) Flaxseed proteins: A review. Food Chem 48:109-114.
3. Kelley DS, Branch LB, Love JE, Taylor PC, Rivera YM, Iacono JM (1991) Dietary alpha-linolenic acid and immunocompetence in humans. Am J Clin Nutr 53:40-46.
4. Hunter JE (1990) N-3 fatty acids from vegetable oils. Am J Clin Nutr 51:809-814.
5. Prasad K, Mantha SV, Muir AD, Westcott ND (1998) Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136:367-375.
6. Westcott ND, Muir AD (1998) Process for extracting lignans from flaxseed. US Patent No. 5705618.
7. Prasad K (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Circulation 99:1355-1362.
8. Gavaler JS, Rosenblum ER, Deal SR, Bowie BT (1995) The phytoestrogen congeners of alcoholic beverages: Current status. Proc Soc Exp Biol Med 208:98-102.
9. Obermeyer WR, Musser SM, Betz JM, Casey RE, Pohland AE, Page SW (1995) Chemical studies of phytoestrogens and related compounds in dietary supplements: Flax and chaparral. Proc Soc Exp Biol Med 208:6-12.
10. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: A placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 86:3053-3060.
11. Washburn S, Burke GL, Morgan T, Anthony M (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7-13.
12. Garay RP, Alvarez-Guerra M, Aida JO, Nazaret C, Soler A, Vargas F (1998) Regulation of renal Na-K-Cl cotransporter NKCC2 by humoral natriuretic factors: Relevance in hypertension. Clin Exp Hypertens 20:675-682.
13. Simons LA, Von Konigsmark M, Simons J, Celermajer DS (2000) Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy postmenopausal women. Am J Cardiol 85:1297-1301.
14. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P (1993) Beneficial effect of oestrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 342:133-136.
15. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III (1994) Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786-791.
16. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO III (1997) The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 96:2795-2801.
17. Raddino R, Manca C, Poli E, Bolognesi R, Visioli O (1986) Effects of 17 β-estradiol on isolated rabbit heart. Arch Intl Pharmacodyn Ther 281:57-65.
18. 2α-mediated contraction of the porcine coronary artery. Adv Prost Thromb Leukot Res 19:277-280.
19. Salas E, Lopez MG, Villarroya M, Sanchez-Garcia P, De Pascual R, Dixon WR, Garcia AG (1994) Endothelium-dependent relaxation by 17α-estradiol of pig coronary arteries. Eur J Pharmacol 258:47-55.
20. Gisclard V, Miller VM, Vanhoutte PM (1988) Effect of estradiol on endothelium-dependent responses in rabbit. J Pharmacol Exp Ther 244:19-22.
21. Prasad K, Kalra J, Chaudhary AK, Debnath D (1990) Effect of polymorphonuclear leukocyte-derived oxygen free radicals and hypochlorous acid on cardiac function and some biochemical parameters. Am Heart J 119:538-550.
22. Kapoor R, Prasad K (1996) Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Radic Biol Med 21:609-618.
23. Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B (1996) Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28:375-385.
24. Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells sythesize nitric oxide from L-arginine. Nature 333:664-666.
25. Baker N, Sipkema E (1997) Components of acetylcholine-induced dilation in isolated rat arterioles. Am J Physiol (Heart Circ Physiol) H1848-H1853.
26. 2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br J Pharmacol 120:695-701.
27. Thomson K, Rubin I, Lauritzen M (2000) In vivo mechanisms of acetylcholine-induced vasodilation in rat sciatic nerve. Am J Physiol (Heart Circ Physiol) 279:H1044-H1054.
28. Rees DD, Palmer RMJ, Hudson HF, Moncada S (1989) A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 96:418-424.
29. Randall MD, Kendall DA (1997) Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 335:205-209.
30. Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans P (1990) Hyptensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists:X. Hypertension 15:459-468.
31. 2-induced modulation of airway smooth muscle. Am J Physiol 263:L714-L722.
32. Goren MZ, Akici A, Karaalp A, Aker R, Oktay S (2001) The role of nitric oxide in the reversal of hemorrhagic shock by oxotremorine. Eur J Pharmacol 428:261-267.
33. Hua TC, Moochhala SM (2000) Role of nitric oxide in hemorrhagic shock-induced bacterial translocation. J Surg Res 93:247-256.
34. Martin WGM, Villani D, Jothianandan D, Furchgott RF (1985) Selective blockade of epithelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232:708-716.
35. Jain NK, Patil CS, Singh A, Kulkarni SK (2001) Sildenafil-induced peripheral analgesia and activation of nitric oxide-cyclic GMP pathway. Brain Res 909:170-178.
36. Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC (2002) The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg 94:824-829.
37. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Inhibition of nitric oxide-sensitive guanylyl cyclase by oxidiazoloquinoxaline derivative, ODQ. Mol Pharmacol 48:184-188.
38. Brunner F, Schmidt K, Nielsen EB, Mayer B (1996) Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther 277:48-53.
39. Martin W, Drazan KM, Newby AC (1989) Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Br J Pharmacol 97:51-56.
40. Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367-374.
41. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HH, Thompson LU (1996) Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126:2012-2019.
42. Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9:220-225.
43. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetyl-choline. Nature 288:373-376.
44. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhari G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269.
45. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ (1986) Activation of purified soluble guanylate cyclase by endothelial-derived relaxing factor from intrapulmonary artery and vein: Stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 237:893-900.
46. Martin W, White DG, Henderson AH (1988) Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol 93:229-239.
47. Ignarro LJ, Kadowitz PJ (1985) Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann Rev Pharmacol Toxicol 25:171-191.
48. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AI, Kadowitz PJ, Gruetter CA (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749.
49. Rees DD, Palmer RM, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375-3378.
50. Feelisch M (1991) The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solution. J Cardiovasc Pharmacol 17(Suppl 3):S25-S33.
51. Waldman SA, Murad F (1988) Biochemical mechanisms underlying vascular smooth muscle relaxation: The cyclase-cyclic GMP system. J Cardiovasc Pharmacol 12(Suppl. 5):S115-S118.
52. Mittal CK, Murad F (1977) Activation of guanylate cyclase with superoxide dismutase and hydroxyl radical, a physiological regulator of cyclic GMP formation. Proc Natl Acad Sci USA 74:4360-4364.
53. Prasad K, Bharadwaj LA (1996) Hydroxyl radical - a mediator of acetylcholine-induced vascular relaxation. J Mol Cell Cardiol 28:2033-2041.
54. Bharadwaj LA, Prasad K (1997) Mechanism of hydroxyl radical-induced modulation of vascular tone. Free Radic Biol Med 22:381-390.